We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04866069
Recruitment Status : Terminated (Although cellular responses to virus were satisfactory, neutralizing titres against virus were lower then expected levels)
First Posted : April 29, 2021
Last Update Posted : April 18, 2023
The Scientific and Technological Research Council of Turkey
Information provided by (Responsible Party):
Osman ERGANIS, PhD, Prof, The Scientific and Technological Research Council of Turkey

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 5, 2021
Actual Study Completion Date : September 5, 2021